About LENSAR, Inc. 
LENSAR, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 9 Schemes (10.59%)
Foreign Institutions
Held by 18 Foreign Institutions (3.48%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
14 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
USD 147 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
2.13
150.63%
-15.89






